3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
78
Neoplasm Metastasis
16
Neoplasms
9
Breast Neoplasms, Male
9
Brain Neoplasms
6
Urinary Bladder Neoplasms
5
Ovarian Neoplasms
5
Head and Neck Neoplasms
4
Colorectal Neoplasms
4
Unspecified Adult Solid Tumor, Protocol Specific
3
Prostatic Neoplasms
3
Lung Neoplasms
3
Carcinoma, Squamous Cell
3
Carcinoma, Ovarian Epithelial
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Solid Tumors
2
Pancreatic Neoplasms
2
Neuroma, Acoustic
2
Neurofibromatosis 2
2
Inflammatory Breast Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Ductal, Breast
2
Salivary Gland Neoplasms
1
Recurrence
1
Prolactinoma
1
Pituitary Neoplasms
1
Patient Compliance
1
Neuroectodermal Tumors, Primitive
1
Interventions
Blood Specimen Collection
25
Reverse Transcriptase Polymerase Chain Reaction
7
Flow Cytometry
7
Liquid Biopsy
4
cabazitaxel
3
Surgical Procedures, Operative
3
Propofol
3
Carboplatin
3
Bevacizumab
3
Trastuzumab
2
Spinal Puncture
2
Sevoflurane
2
Positron Emission Tomography Computed Tomography
2
Pirinitramide
2
Neoadjuvant Therapy
2
Morphine
2
Laparoscopy
2
Hematologic Tests
2
Folfox protocol
2
Epirubicin
2
Drug Therapy
2
Docetaxel
2
Cyclophosphamide
2
Cisplatin
2
Cetuximab
2
Capecitabine
2
Aspirin
2
Anesthesia, General
2
ribociclib
1
pertuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplastic Cells, Circulating
×
Lapatinib
×
Clear all
NCT01619111
2024-06-04
DETECT III
University of Ulm
Phase 3
Completed
105 enrolled